Inhalation Therapy Nebulizer Market valued USD 1,969.4 Mn in 2021 and is estimated to USD 3,039.3 Mn by 2028, at CAGR of 23.50% from 2022-2028.
FrequentlyAsked Questions
The rising global incidence of respiratory illnesses, as well as the growing elderly population, are expected to drive market expansion throughout the forecast period. In addition, rising demand for new respiratory medication delivery devices, as well as their rapid adoption among the patient population, are expected to drive their utilization over the forecast period.
According to the Market Research report, the Inhalation Therapy Nebulizer Market was worth about 1,969.4 (USD million) in 2021 and is predicted to grow to around 3,039.3 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 7.5 percent.
North America dominated the global inhalation therapy nebulizer market in the forecast period. A higher prevalence of asthma and other chronic respiratory illnesses, as well as increased use of advanced portable ones in the region, have contributed to North America having a larger share of the global market.
Some of the main competitors dominating the Inhalation Therapy Nebulizer Market include - Rossmax International Ltd., OMRON Corporation, Koninklijke Philips N.V., PARI Pharma, BD, Medline Industries, Inc., Briggs Healthcare, GF Health Products, Inc., Vectura Group plc, Beurer GmBH.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed